Athira pharma to participate in panel discussion at sachs 4th annual neuroscience innovation forum

Bothell, wash., april 21, 2021 (globe newswire) -- athira pharma, inc. (nasdaq: atha), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced that leen kawas, ph.d., president and chief executive officer, will participate in a virtual panel discussion at the sachs 4th annual neuroscience innovation forum. the panel, titled “progress in alzheimer's and dementia,” will be aired on wednesday, april 28, 2021, at 8:30 a.m. pt /11:30 a.m. et.
ATHA Ratings Summary
ATHA Quant Ranking